Linda Kusner PhD

Linda L. Kusner, PhD, is an associate professor in the Department of Pharmacology & Physiology at The George Washington University in Washington DC. Dr. Kusner’s research focuses on the pathophysiology of myasthenia gravis. She has performed extensive evaluations of the role of complement in myasthenia gravis pathogenesis, which led to a patent for an approach to concentrate complement inhibitors to the neuromuscular junction. Dr. Kusner was the first to discover the role of the anti-apoptotic protein, survivin, in the pathology of human and animal models of myasthenia gravis. Her laboratory works closely with industry partners for the assessment of potential MG therapeutics. Dr. Kusner directs MGNet’s pilot study program.